Mesenchymal Stem Cell‐Derived Exosomes as a Double‐Edged Sword: Balancing Inflammation and Immunosuppression in Human Papillomavirus‐Infected Tissues
Stem Cells International · 2026-01 · 2026 (1)
DOI: 10.1155/sci/2596453 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cells International, online erschienen am 19.07.2026. Verfasst von Fatemeh Poorhoseini Hanzaii und 2 weiteren Autor:innen. Beteiligte Einrichtung: Applied Cell Sciences Division, Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran, modares.ac.ir. Die Arbeit nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Human papillomavirus (HPV) infection is the most common sexually transmitted viral infection, strongly associated with chronic inflammation and cervical cancer progression in women. Persistent HPV infection leads to an inflammatory microenvironment that promotes epithelial dysplasia and immune evasion. Exosomes derived from mesenchymal stem cells (MSC‐exosomes) have emerged as promising immunomodulatory and anti‐inflammatory agents. This review examines current evidence on the interaction between HPV‐induced inflammation and exosomal signaling, with a particular focus on the therapeutic potential of MSC‐exosomes. We discuss their roles in immune regulation, miRNA delivery, suppression of nuclear factor kappa‐light‐chain‐enhancer of activated B cells (NF‐κB) signaling, and epithelial regeneration. This anti‐inflammatory effect may also impair local immune surveillance, potentially enabling viral persistence and progression to malignancy. In this narrative review, We reviewed PubMed, Scopus, and Web of Science articles published up to 2024 on MSC‐exosome interactions with immune regulation in HPV‐related diseases. Evidence suggests that while the anti‐inflammatory effects of MSC‐exosomes may help control HPV‐associated inflammation, they can also impair local immune surveillance, potentially facilitating viral persistence and progression toward malignancy. This dual activity positions MSC‐exosomes as a double‐edged sword in the context of HPV pathogenesis. A deeper understanding of this paradox is essential for designing safer, context‐specific MSC‐based therapies that balance anti‐inflammatory benefits with effective antiviral immune responses. Although direct studies on MSC‐exosomes in HPV infections are limited, existing models suggest that they have the capacity to attenuate inflammation and restore cervical tissue homeostasis. This article also highlights knowledge gaps and future research directions necessary to develop MSC‐exosome‐based therapies for HPV‐related cervical diseases.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Applied Cell Sciences Division, Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran, modares.ac.ir.
- Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran, sbmu.ac.ir.
ORCID-Profile: Fatemeh Poorhoseini Hanzaii, Masoud Soleimani, Mina SoufiZomorrod
Zitieren
APA
Poorhoseini Hanzaii, F., Soleimani, M., & SoufiZomorrod, M. (2026). Mesenchymal Stem Cell‐Derived Exosomes as a Double‐Edged Sword: Balancing Inflammation and Immunosuppression in Human Papillomavirus‐Infected Tissues. Stem Cells International, 2026(1). https://doi.org/10.1155/sci/2596453
Vancouver
Poorhoseini Hanzaii F, Soleimani M, SoufiZomorrod M. Mesenchymal Stem Cell‐Derived Exosomes as a Double‐Edged Sword: Balancing Inflammation and Immunosuppression in Human Papillomavirus‐Infected Tissues. Stem Cells International. 2026;2026(1). doi:10.1155/sci/2596453
BibTeX
@article{PoorhoseiniHanzaii2026,
author = {Poorhoseini Hanzaii, Fatemeh and Soleimani, Masoud and SoufiZomorrod, Mina},
title = {Mesenchymal Stem Cell‐Derived Exosomes as a Double‐Edged Sword: Balancing Inflammation and Immunosuppression in Human Papillomavirus‐Infected Tissues},
journal = {Stem Cells International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/sci/2596453}
}
EUVIMED